Connect with us

Hi, what are you looking for?

News

ANI Pharmaceuticals Stock: Strong Revenue Growth, ANDA Approvals (ANIP)

On May 8, ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) beat Q1 Non-GAAP earnings expectations by more than triple the consensus estimate. Revenue grew 65.6% year-over-year and guidance was raised to the range of $385 Million to $410 Million from the range

Ani Pharmaceuticals, Inc.

Ani Pharmaceuticals, Inc.

Chart
Data by YCharts

Chart
Data by YCharts

Chart
Data by YCharts

Chart
Data by YCharts

Read the full article here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Uncategorized

Artikuj Aplikacioni SpinBetter për iOS: Kazino Dragonslots Cilat janë fitimet e kufizimit në lidhje me Historinë larg hostit të slotit të vdekur? Luaj video...

Uncategorized

Blogs Renault – 2 Constructors’ headings, 2 Rider headings: golf betting betway McLaren – 9 Constructors’ titles, twelve Driver headings FIA releases F1 2025...

Uncategorized

(Inspire Las vegas also provides a grip and you will Twist group.) There are also Megaways ports, which happen to be personally offered by...

Uncategorized

Articles Wonder Competitors: All Up coming Characters, Team-Ups and you will Maps Master Shark Faq’s: Ways to Your Greatest Questions relating to Wazdan’s Preferred...